Clinical Trial Update: Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the efficacy and safety of the YUKON Drug Eluting Stent for diffuse coronary artery disease in patients with acute coronary syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• YUKON Drug Eluting Stent

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Acute Coronary Syndromes | Phase 4 | Status: UNKNOWN